Matches in SemOpenAlex for { <https://semopenalex.org/work/W2093889766> ?p ?o ?g. }
Showing items 1 to 83 of
83
with 100 items per page.
- W2093889766 endingPage "583" @default.
- W2093889766 startingPage "575" @default.
- W2093889766 abstract "Clarithromycin has a wide spectrum of activity against many gram-positive and gram-negative organisms, intracellular pathogens, and opportunistic pathogens. To examine the penetration of clarithromycin in the ocular tissues, 21 patients who underwent elective cataract surgery (Group I) received a single 500-mg dose of clarithromycin orally either 4, 8, 10, 12, or 22 hours before cataract surgery, and 21 patients who underwent elective retina/vitreous surgery (Group II) received 500 mg every 12 hours orally for 3 days before the surgery with the last dose given either 3, 6, 8, 11, or 24 hours before the surgery. Serum from all patients was assayed for clarithromycin prior to drug administration and at the time ocular specimen was taken. Aqueous, iris, and vitreous samples were also assayed for clarithromycin concentration. The concentrations of clarithromycin in the aqueous fluid 4, 8, 10, 12, and 22 hours after administration were: (mean ± SD) 0.13±0.05, 0.137±0.11, 0.074±0.03, 0.06±0.02, and 0.074±0.04 μg/ml, respectively. Concentration of clarithromycin in vitreous 3, 6, 8, 11, and 24 hours after administration were: (mean ± SD) 0.11 ±0.02, 0.257±0.13, 0.27±0.21, 0.307±0.26 and 0.108±0.07 μg/ml, respectively. The mean concentration of clarithromycin in the iris was 6.2 μg/g. In conclusion, this data suggest that clarithromycin widely penetrates and adequately concentrates in the aqueous humor, vitreous humor, and iris tissue after oral administration and therefore is effective in the management of many infectious ocular conditions." @default.
- W2093889766 created "2016-06-24" @default.
- W2093889766 creator A5017669643 @default.
- W2093889766 creator A5049679138 @default.
- W2093889766 creator A5064001527 @default.
- W2093889766 creator A5066153085 @default.
- W2093889766 date "1998-12-01" @default.
- W2093889766 modified "2023-09-25" @default.
- W2093889766 title "Ocular Penetration of Oral Clarithromycin in Humans" @default.
- W2093889766 cites W1971324161 @default.
- W2093889766 cites W2007970667 @default.
- W2093889766 cites W2033343893 @default.
- W2093889766 cites W2059060527 @default.
- W2093889766 cites W2077718144 @default.
- W2093889766 cites W2090196018 @default.
- W2093889766 cites W2125368948 @default.
- W2093889766 cites W2318411594 @default.
- W2093889766 doi "https://doi.org/10.1089/jop.1998.14.575" @default.
- W2093889766 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/9867340" @default.
- W2093889766 hasPublicationYear "1998" @default.
- W2093889766 type Work @default.
- W2093889766 sameAs 2093889766 @default.
- W2093889766 citedByCount "9" @default.
- W2093889766 countsByYear W20938897662017 @default.
- W2093889766 countsByYear W20938897662019 @default.
- W2093889766 countsByYear W20938897662020 @default.
- W2093889766 crossrefType "journal-article" @default.
- W2093889766 hasAuthorship W2093889766A5017669643 @default.
- W2093889766 hasAuthorship W2093889766A5049679138 @default.
- W2093889766 hasAuthorship W2093889766A5064001527 @default.
- W2093889766 hasAuthorship W2093889766A5066153085 @default.
- W2093889766 hasConcept C118487528 @default.
- W2093889766 hasConcept C141071460 @default.
- W2093889766 hasConcept C2775888743 @default.
- W2093889766 hasConcept C2776409635 @default.
- W2093889766 hasConcept C2776962512 @default.
- W2093889766 hasConcept C2777056448 @default.
- W2093889766 hasConcept C2993390227 @default.
- W2093889766 hasConcept C3019249092 @default.
- W2093889766 hasConcept C42219234 @default.
- W2093889766 hasConcept C501593827 @default.
- W2093889766 hasConcept C71924100 @default.
- W2093889766 hasConcept C86803240 @default.
- W2093889766 hasConcept C89423630 @default.
- W2093889766 hasConcept C90924648 @default.
- W2093889766 hasConcept C98274493 @default.
- W2093889766 hasConceptScore W2093889766C118487528 @default.
- W2093889766 hasConceptScore W2093889766C141071460 @default.
- W2093889766 hasConceptScore W2093889766C2775888743 @default.
- W2093889766 hasConceptScore W2093889766C2776409635 @default.
- W2093889766 hasConceptScore W2093889766C2776962512 @default.
- W2093889766 hasConceptScore W2093889766C2777056448 @default.
- W2093889766 hasConceptScore W2093889766C2993390227 @default.
- W2093889766 hasConceptScore W2093889766C3019249092 @default.
- W2093889766 hasConceptScore W2093889766C42219234 @default.
- W2093889766 hasConceptScore W2093889766C501593827 @default.
- W2093889766 hasConceptScore W2093889766C71924100 @default.
- W2093889766 hasConceptScore W2093889766C86803240 @default.
- W2093889766 hasConceptScore W2093889766C89423630 @default.
- W2093889766 hasConceptScore W2093889766C90924648 @default.
- W2093889766 hasConceptScore W2093889766C98274493 @default.
- W2093889766 hasIssue "6" @default.
- W2093889766 hasLocation W20938897661 @default.
- W2093889766 hasLocation W20938897662 @default.
- W2093889766 hasOpenAccess W2093889766 @default.
- W2093889766 hasPrimaryLocation W20938897661 @default.
- W2093889766 hasRelatedWork W158479642 @default.
- W2093889766 hasRelatedWork W1984417460 @default.
- W2093889766 hasRelatedWork W2024015829 @default.
- W2093889766 hasRelatedWork W2032718544 @default.
- W2093889766 hasRelatedWork W2058780534 @default.
- W2093889766 hasRelatedWork W2065023395 @default.
- W2093889766 hasRelatedWork W2093889766 @default.
- W2093889766 hasRelatedWork W2105232139 @default.
- W2093889766 hasRelatedWork W2129757466 @default.
- W2093889766 hasRelatedWork W2130749922 @default.
- W2093889766 hasVolume "14" @default.
- W2093889766 isParatext "false" @default.
- W2093889766 isRetracted "false" @default.
- W2093889766 magId "2093889766" @default.
- W2093889766 workType "article" @default.